臨床試驗

Werewolf Flow 50 During ACL Reconstruction

NCT：NCT04998656 · COMPLETED

NCT IDNCT04998656

狀態COMPLETED

開始日期2021-07-12

完成時間2024-11-02

SponsorUniversity of Colorado, Denver (OTHER)

First posted2021-08-10

Last updated2026-09-14

簡要摘要

The aim of this study is to compare the outcomes, ease of use, and cost of the Werewolf FLOW50 device to the institutional standard of care which is does not include the use of electrocautery devices during anterior cruciate ligament reconstruction (ACLR) surgery in patients 12-18 years of age using a randomized control trial design. The investigators hypothesize that a lower proportion of participants who undergo ACLR and are randomized to the Werewolf FLOW50 procedure will experience post-operative arthrofibrosis compared to those randomized to standard of care (control group).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。